Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (19)

2024

  1. Exploring CD26−/lo subpopulations of lymphocytes in asthma phenotype and severity: A novel CD4+ T cell subset expressing archetypical granulocyte proteins

    Allergy: European Journal of Allergy and Clinical Immunology

  2. Signature Proteins in Small Extracellular Vesicles of Granulocytes and CD4+ T-Cell Subpopulations Identified by Comparative Proteomic Analysis

    International Journal of Molecular Sciences, Vol. 25, Núm. 19

  3. Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 656-666

2023

  1. Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial

    American journal of respiratory and critical care medicine, Vol. 207, Núm. 9, pp. 1161-1170

  2. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  3. Prognostic Usefulness of Basic Analytical Data in Chronic Obstructive Pulmonary Disease Exacerbation

    Open Respiratory Archives, Vol. 5, Núm. 4

  4. Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 141-155

2022

  1. Association of rhinitis with asthma prevalence and severity

    Scientific Reports, Vol. 12, Núm. 1

  2. Proteomic analysis of food allergens

    Food Proteomics: Technological Advances, Current Applications and Future Perspectives (Elsevier), pp. 225-300

  3. The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids

    ERJ Open Research

2021

  1. Efficacy of mepolizumab in usual clinical practice and characteristics of responders: Mepolizumab in usual clinical practice

    Respiratory Medicine, Vol. 187

2020

  1. Obesity does not increase the risk of Asthma readmissions

    Journal of Clinical Medicine, Vol. 9, Núm. 1

  2. iTRAQ-based proteomic analysis reveals potential serum biomarkers of allergic and nonallergic asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 12, pp. 3171-3183

2019

  1. Expansion of different subpopulations of CD26 −/low T cells in allergic and non-allergic asthmatics

    Scientific Reports, Vol. 9, Núm. 1

  2. Blood eosinophils could be useful as a biomarker in chronic obstructive pulmonary disease exacerbations

    International Journal of Clinical Practice, Vol. 73, Núm. 12

  3. CD26 and Asthma: a Comprehensive Review

    Clinical Reviews in Allergy and Immunology, Vol. 56, Núm. 2, pp. 139-160

2018

  1. Association between blood eosinophil count with asthma hospital readmissions

    European Journal of Internal Medicine, Vol. 53, pp. 34-39

  2. Expansion of a CD26low effector th subset and reduction in circulating levels of sCD26 in stable allergic asthma in adults

    Journal of Investigational Allergology and Clinical Immunology, Vol. 28, Núm. 2, pp. 113-125

  3. The CD14 (-159 C/T) SNP is associated with sCD14 levels and allergic asthma, but not with CD14 expression on monocytes

    Scientific Reports, Vol. 8, Núm. 1